Jump to navigation Jump to search

WikiDoc Resources for Hyperoxaluria


Most recent articles on Hyperoxaluria

Most cited articles on Hyperoxaluria

Review articles on Hyperoxaluria

Articles on Hyperoxaluria in N Eng J Med, Lancet, BMJ


Powerpoint slides on Hyperoxaluria

Images of Hyperoxaluria

Photos of Hyperoxaluria

Podcasts & MP3s on Hyperoxaluria

Videos on Hyperoxaluria

Evidence Based Medicine

Cochrane Collaboration on Hyperoxaluria

Bandolier on Hyperoxaluria

TRIP on Hyperoxaluria

Clinical Trials

Ongoing Trials on Hyperoxaluria at Clinical Trials.gov

Trial results on Hyperoxaluria

Clinical Trials on Hyperoxaluria at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hyperoxaluria

NICE Guidance on Hyperoxaluria


FDA on Hyperoxaluria

CDC on Hyperoxaluria


Books on Hyperoxaluria


Hyperoxaluria in the news

Be alerted to news on Hyperoxaluria

News trends on Hyperoxaluria


Blogs on Hyperoxaluria


Definitions of Hyperoxaluria

Patient Resources / Community

Patient resources on Hyperoxaluria

Discussion groups on Hyperoxaluria

Patient Handouts on Hyperoxaluria

Directions to Hospitals Treating Hyperoxaluria

Risk calculators and risk factors for Hyperoxaluria

Healthcare Provider Resources

Symptoms of Hyperoxaluria

Causes & Risk Factors for Hyperoxaluria

Diagnostic studies for Hyperoxaluria

Treatment of Hyperoxaluria

Continuing Medical Education (CME)

CME Programs on Hyperoxaluria


Hyperoxaluria en Espanol

Hyperoxaluria en Francais


Hyperoxaluria in the Marketplace

Patents on Hyperoxaluria

Experimental / Informatics

List of terms related to Hyperoxaluria

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

ICD-10 E74.8
ICD-9 271.8
DiseasesDB 31642
eMedicine med/3027 
MeSH D006959


Hyperoxaluria is an excessive urinary excretion of oxalate. Individuals with hyperoxaluria often have calcium oxalate kidney stones. It is sometimes called Bird's disease, after Golding Bird, who first described the condition.

Historical Perspective



  • Primary hyperoxaluria
  • Enteric hyperoxaluria
  • Idiopathic hyperoxaluria
  • Oxalate poisoning



Perhaps the key difficulty in understanding pathogenesis of primary hyperoxaluria, or more specifically, why AGXT ends up in mitochondria instead of peroxisomes, stems from AGXT's somewhat peculiar evolution. Namely, prior to its current peroxysomal 'destiny', AGXT indeed used to be bound to mitochondria. AGXT's peroxisomal targeting sequence is uniquely specific for mammalian species, suggesting the presence of additional peroxisomal targeting information elsewhere in the AGT molecule. As AGXT was redirected to peroxisomes over the course of evolution, it is plausible that its current aberrant localization to mitochondria owes to some hidden molecular signature in AGXT's spatial configuration unmasked by PH1 mutations affecting the AGXT gene.


Type I (PH1) is associated with AGXT protein, a key enzyme involved in breakdown of oxalate. PH1 is also an example of a protein mistargeting disease, wherein AGXT shows a trafficking defect: instead of being trafficked to peroxisomes, it is targeted to mitochondria, where it is metabolically deficient despite being catalytically active. Type II is associated with GRHPR.[1] It is also a complication of jejunoileal bypass, or in any patient who has lost much of the ileum with an intact colon. This is due to excessive absorption of oxalate from the colon.[2]

Differentiating Hyperoxaluria from Other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications, and Prognosis


Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Imaging Findings

Other Diagnostic Studies


The main therapeutic approach to primary hyperoxaluria is still restricted to symptomatic treatment, i.e. kidney transplantation once the disease has already reached mature or terminal stages. However, through genomics and proteomics approaches, efforts are currently being made to elucidate the kinetics of AGXT folding which has a direct bearing on its targeting to appropriate subcellular localization. Secondary hyperoxaluria is much more common than primary hyperoxaluria, and should be treated by limiting dietary oxalate and providing calcium supplementation. A child with primary hyperoxaluria was treated with a liver and kidney transplant.[3] A favorable outcome is more likely if a kidney transplant is complemented by a liver transplant, given the disease originates in the liver.

Medical Therapy



External links


  1. "Primary hyperoxaluria - Genetics Home Reference".
  2. Surgery PreTest Self-Assessment and Review, Twelfth Edition
  3. India News & Business - MSN India: News, Business, Finance, Sports, Politics & more. - News

Template:Inborn errors of carbohydrate metabolism

Template:WS Template:WH